Ousseny Zerbo1, Sharareh Modaressi2, Berwick Chan2, Kristin Goddard2, Ned Lewis2, Karin Bok3, Bruce Fireman2, Nicola P Klein2, Roger Baxter2. 1. Kaiser Permanente Vaccine Study Center, 1 Kaiser Plaza, 16B, Oakland, CA 94612, USA. Electronic address: ousseny.x.zerbo@kp.org. 2. Kaiser Permanente Vaccine Study Center, 1 Kaiser Plaza, 16B, Oakland, CA 94612, USA. 3. National Vaccine Program Office, Office of the Assistant Secretary for Health, US Department of Health and Human Services, USA.
Abstract
BACKGROUND: Pregnant women are recommended to receive inactivated influenza vaccination anytime during pregnancy. Studies have investigated the impact of influenza vaccination during pregnancy on birth outcomes and results on preterm birth have been inconsistent. METHODS: We conducted a retrospective cohort study among children born at a gestational age≥24weeks from January 1, 2010 to December 31, 2015 at Kaiser Permanente Northern California facilities (KPNC). We evaluated the association between maternal influenza vaccination during pregnancy and risk of preterm birth, small and large for gestational age, admission to the neonatal intensive care unit (NICU), respiratory distress syndrome, low birth weight, and low Apgar score. We ascertained the dates of maternal influenza vaccination, conception, and delivery, as well as birth outcomes from KPNC inpatient and outpatient databases. Conditional multivariate Cox regression and logistic regression analyses were used to determine the association between maternal vaccination during pregnancy and risk of each birth outcome. RESULTS: The study included 145,869 children. Maternal influenza vaccination during pregnancy was not associated with risk of small or large for gestational age births, preterm birth, need for mechanical ventilation at birth, respiratory distress syndrome, admission to the NICU, low birth weight, or low Apgar score. However, when we did not control for immortal time bias, the risk of preterm birth (odds ratio [OR]=0.69, 95% confidence interval [CI] 0.66-0.72) was lower among infants of vaccinated mothers. CONCLUSION: We found no association between maternal influenza vaccination during pregnancy and adverse birth outcomes. When investigating preterm birth outcome in association with vaccination during pregnancy, immortal time bias should be taken into account in the analysis.
BACKGROUND: Pregnant women are recommended to receive inactivated influenza vaccination anytime during pregnancy. Studies have investigated the impact of influenza vaccination during pregnancy on birth outcomes and results on preterm birth have been inconsistent. METHODS: We conducted a retrospective cohort study among children born at a gestational age≥24weeks from January 1, 2010 to December 31, 2015 at Kaiser Permanente Northern California facilities (KPNC). We evaluated the association between maternal influenza vaccination during pregnancy and risk of preterm birth, small and large for gestational age, admission to the neonatal intensive care unit (NICU), respiratory distress syndrome, low birth weight, and low Apgar score. We ascertained the dates of maternal influenza vaccination, conception, and delivery, as well as birth outcomes from KPNC inpatient and outpatient databases. Conditional multivariate Cox regression and logistic regression analyses were used to determine the association between maternal vaccination during pregnancy and risk of each birth outcome. RESULTS: The study included 145,869 children. Maternal influenza vaccination during pregnancy was not associated with risk of small or large for gestational age births, preterm birth, need for mechanical ventilation at birth, respiratory distress syndrome, admission to the NICU, low birth weight, or low Apgar score. However, when we did not control for immortal time bias, the risk of preterm birth (odds ratio [OR]=0.69, 95% confidence interval [CI] 0.66-0.72) was lower among infants of vaccinated mothers. CONCLUSION: We found no association between maternal influenza vaccination during pregnancy and adverse birth outcomes. When investigating preterm birth outcome in association with vaccination during pregnancy, immortal time bias should be taken into account in the analysis.
Authors: Ousseny Zerbo; G Thomas Ray; Lea Zhang; Kristin Goddard; Bruce Fireman; Alyce Adams; Saad Omer; Martin Kulldorff; Nicola P Klein Journal: Am J Epidemiol Date: 2020-11-02 Impact factor: 4.897
Authors: Hassen Mohammed; Claire T Roberts; Luke E Grzeskowiak; Lynne C Giles; Gustaaf A Dekker; Helen S Marshall Journal: EClinicalMedicine Date: 2020-09-09
Authors: Flor M Munoz; Pierre Van Damme; Ener Dinleyici; Ed Clarke; Beate Kampmann; Paul T Heath; Ofer Levy; Elke Leuridan; Clare Cutland; Ajoke Sobanjo-Ter Meulen; Arnaud Marchant Journal: mSphere Date: 2018-11-07 Impact factor: 4.389
Authors: Mohinder Sarna; Ross Andrews; Hannah Moore; Michael J Binks; Lisa McHugh; Gavin F Pereira; Christopher C Blyth; Paul Van Buynder; Karin Lust; Paul Effler; Stephen B Lambert; Saad B Omer; Donna B Mak; Thomas Snelling; Heather A D'Antoine; Peter McIntyre; Nicholas de Klerk; Damien Foo; Annette K Regan Journal: BMJ Open Date: 2019-06-20 Impact factor: 2.692